Cargando…
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
Treatment with nitisinone (NTBC) has brought about a drastic improvement in the treatment and prognosis of hereditary tyrosinemia type I (HT1). We conducted a retrospective observational multicentric study in Spanish HT1 patients treated with NTBC to assess clinical and biochemical long-term evoluti...
Autores principales: | Couce, María Luz, Sánchez-Pintos, Paula, Aldámiz-Echevarría, Luís, Vitoria, Isidro, Navas, Victor, Martín-Hernández, Elena, García-Volpe, Camila, Pintos, Guillem, Peña-Quintana, Luis, Hernández, Tomás, Gil, David, Sánchez-Valverde, Félix, Bueno, María, Roca, Iria, López-Ruzafa, Encarna, Díaz-Fernández, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775438/ https://www.ncbi.nlm.nih.gov/pubmed/31574857 http://dx.doi.org/10.1097/MD.0000000000017303 |
Ejemplares similares
-
Treatment adherence in tyrosinemia type 1 patients
por: González-Lamuño, Domingo, et al.
Publicado: (2021) -
Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle
por: Andrade, Fernando, et al.
Publicado: (2017) -
Arterial stiffness assessment in patients with phenylketonuria
por: Hermida-Ameijeiras, Alvaro, et al.
Publicado: (2017) -
A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project – a 2-year follow-up study
por: Colón, Cristóbal, et al.
Publicado: (2017) -
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia
por: Couce, María L., et al.
Publicado: (2016)